Humana reported a solid start to 2026 with strong first-quarter results, driven by effective operational execution and strategic transformation initiatives. The company affirmed its full-year adjusted financial guidance, demonstrating confidence in its ongoing strategy despite some year-over-year declines in GAAP metrics.
Adjusted EPS of $10.31, at the high end of guidance and reflecting strong operational execution.
positiveInsurance segment GAAP benefit ratio of 89.4 percent, slightly favorable to management's guidance.
positiveAffirmed full year 2026 Adjusted EPS guidance of 'at least $9.00'.
positiveAffirmed FY 2026 individual Medicare Advantage (MA) membership growth of 'approximately 25 percent'.
positiveSequential growth of 110,500 patients in CenterWell Senior Primary Care, including acquisition of MaxHealth.
positive1Q26 state-based contracts membership growth of approximately 50,000.
positiveGAAP EPS revised downwards to 'at least $8.36' from 'at least $8.89'.
negativeFY 2026 Adjusted EPS guidance anticipates a year-over-year decline due to Star Ratings headwind.
negativeDecline in Star Ratings will negatively impact 2026 quality bonus payments from CMS and may adversely affect revenues, operating results, and cash flows.
negativeYear-over-year decline in GAAP pretax results ($1,595M vs $1,691M) and Adjusted pretax results ($1,670M vs $1,893M).
negativeYear-over-year decline in GAAP EPS ($9.83 vs $10.30) and Adjusted EPS ($10.31 vs $11.58).
negativeInsurance Segment GAAP income from operations decreased to $1,435M from $1,574M YoY.
negativeMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
| Segment | Current | Prior Yr | YoY | % Total |
|---|---|---|---|---|
Insurance Segment | N/A | — | — | — |
| Total Revenue | $0.00M | — | — | 100.0% |
Segment performance shows business unit health and growth drivers.
Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.
Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.
Solid start to the year and feel good about how operating execution and transformation initiatives are setting us up for the future.
Continue to make progress where it counts for customers - quality experience and outstanding care.
Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.